The National Cancer Institute of Milan (INT), established in 1928, stands as a center of excellence for pre-clinical, translational and clinical research activities, and clinical care. INT has 464 inpatient beds and provides more than 400,000 outpatient visits per year. The Institute carries out a public service characterized by a high level of diagnostic therapeutic and research activities.
The Institute has programs and projects in every field and phase of research, preclinical, epidemiological, public health and clinical. INT is the Italian coordinator of numerous national and international clinical trials also with early phase studies.
The center is totally dedicated to the cure of cancer and is divided into different departments that come together in: medical oncology, hematology, surgery and radiotherapy.